Fundraising Fox

Visgenx

San Diego, US · Founded 2018 · Delaware corporation · 1 employees on LinkedIn · 1 known investors

Biotech

Founders & leadership

SV
Santosh VetticadenNamed on SEC filing
ME
Martin EmanueleNamed on SEC filing
FD
Frank DouglasNamed on SEC filing

Investors · 1

Cove FundIrvine · $250K – $1M

Reported raises · per SEC filings

Form D private placements

$9.2M disclosed across 3 rounds · 2019–2023

▶$2.8MraisedJun 2023 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin Emanuele, Ph.D.Executive Officer, Director
  • Thomas Meier, Ph.D., M.D.Director
  • Elaine Heron, Ph.D.Director
  • William PedrantiExecutive Officer, Director
  • Arthur BeckerDirector
  • Santosh Vetticaden, Ph.D., M.D.Director
  • Eric Carter, Ph.D., M.D.Director
Offering amount
$3.5M
Amount sold
$2.8M
First sale
Jun 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedAug 2020 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin Emanuele, Ph.D.Executive Officer, Director
  • Santosh Vetticaden, M.D., Ph.D., MBAExecutive Officer, Director
  • Elaine Heron, Ph.D.Director
  • Arthur BeckerDirector
  • Frank Douglas, M.D., Ph.D.Director
Offering amount
$5.7M
Amount sold
$5.7M
First sale
May 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$655KraisedJul 2019 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Santosh VetticadenExecutive Officer, Director
  • Martin EmanueleExecutive Officer, Director
  • Frank DouglasDirector
Offering amount
$2.2M
Amount sold
$655K
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Visgenx Appoints William Pedranti as Chief Executive Officerprnewswire.com · Jun 2023San Diego California based Visgenx is raising $5,625,266.00 in New Equity Investment. - intelligence360intelligence360.news · Jun 2020

Frequently asked questions

Who are Visgenx's investors?
Visgenx's investors include Cove Fund.
How much funding has Visgenx raised?
Visgenx has disclosed $9.2M raised across 3 rounds.
Where is Visgenx headquartered?
Visgenx is headquartered in San Diego, US.